Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Executive War College 2026 to Spotlight AI, Workforce Solutions, and Financial Strategy for Clinical Labs
The 31st Annual Executive War College will convene April 28‑29 in New Orleans, bringing together clinical laboratory executives to address reimbursement, staffing, compliance, and emerging technologies. A new Executive Forum on Digital Pathology Management will spotlight AI‑driven workflows and data integration. The agenda is organized around six themes—financial strategy, workforce, compliance, innovation, AI, and M&A—offering practical, execution‑focused solutions. With roughly 80 sessions and 150 speakers, attendees will leave with actionable roadmaps for 2026 challenges.
Why US Healthcare Is Fundamentally Broken W/ Zeev Neuwirth, Rezilient Health
In this episode, Dr. Zev Neuwirth, a veteran physician and healthcare strategist, explains why the U.S. health system is fundamentally broken, pointing to the collapse of primary care, soaring administrative costs, and the failures of employer‑based insurance. He argues that...
9 Common Conditions Treated by Primary Care Doctors
Primary care physicians handle a wide range of everyday health issues, from respiratory infections to chronic disease screening. The article outlines nine common conditions they treat, emphasizing early detection and continuity of care. It highlights how primary care can spot...
Strength Training Fails to Reduce Knee Stress in Osteoarthritis
An 18‑month strength‑training trial involving 377 knee‑OA patients boosted hip‑abductor, hamstring and quadriceps strength but did not lower knee joint loading or pain. A post‑hoc analysis of the 88 strongest responders confirmed significant muscle gains—45% in quadriceps, 68% in hamstrings,...
MediClin Posts Modest 2025 Growth; Watch 2026 EBIT
MediClin: 2025 revenue +4.8% to €784.5m, EBIT +3.5%. Drivers: post‑acute growth, stable occupancy; acute fell after Heart Centre sale. Risk: narrow 2026 EBIT range. Buy, watch 2026 EBIT. — Viktor Kopylov, PhD, CFA. More insights: t.me/si14Kopylov
How Anesthetics Destabilize the Brain: Scientists Stumble upon Common Mechanism
MIT researchers discovered that three widely used anesthetics—propofol, ketamine and dexmedetomidine—produce an identical destabilization of brain dynamics, measurable as a loss of dynamic stability. Using EEG‑based perturbation analysis, they showed that despite distinct molecular targets, each drug pushes the brain...
HaemaLogiX – Precision Immunotherapy for Multiple Myeloma
HaemaLogiX, an Australian clinical‑stage biotech, is developing precision immunotherapies for multiple myeloma by targeting novel antigens KMA and LMA that appear only on malignant plasma cells. Peer‑reviewed research validates these targets, allowing the company to spare healthy plasma cells and...
Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
The Trump administration touts recent reductions in Affordable Care Act (ACA) enrollment fraud while unveiling a sweeping set of 2027 regulations aimed at tightening eligibility verification and curbing broker misconduct. Complaints about unauthorized enrollments climbed to 341,906 in 2025, prompting...
Northwestern Deploys New Mobile Stroke Unit Equipped with 32-Slice CT Scanner
Northwestern Medicine has upgraded its mobile stroke unit (MSU) with a 32‑slice CT scanner, replacing the older 16‑slice system. The new, smaller‑footprint vehicle can perform advanced imaging en route, allowing clinicians to differentiate ischemic from hemorrhagic strokes before hospital arrival....
Top 5 Ways Healthcare Organizations Can Use Wearable Data Today
Wearable devices have moved beyond consumer hype, offering concrete value for healthcare providers. The article outlines five practical pathways—remote patient monitoring, EHR integration, patient engagement tools, security/compliance foundations, and focused use‑case design—to embed wearable data without overhauling existing IT stacks....
Overactive Bladder Independently Linked to Risk for Recent Fall
A cross‑sectional analysis of 4,118 U.S. adults aged 20‑69, published in *Neurourology and Urodynamics*, found that overactive bladder (OAB) is independently linked to a higher recent‑fall risk. OAB prevalence was 19.6% while 28.3% of participants reported a fall in the...
:max_bytes(150000):strip_icc()/Doctor-Prescribe-Food-Instead-Pills-FT-DGTL0326-4bb1f3563aa84f99aeedcee9688121ce.jpg)
What Happens When Doctors Start Prescribing Food Instead of Pills?
The Rockefeller Foundation’s new report projects that expanding Food Is Medicine programs to the 43 million Americans with diet‑related conditions could generate roughly $45 billion in economic activity, create 316,000 jobs, and funnel more than $5.6 billion to small and mid‑size farms. Medically...
Abcuro Presents the P-II/III (MUSCLE) Study Data on Ulviprubart for Inclusion Body Myositis at GCOM 2026
Abcuro presented Phase II/III MUSCLE trial data for ulviprubart (ABC008) in inclusion body myositis (IBM) at the GCOM 2026 meeting. The study enrolled 272 patients who received either 0.5 mg/kg, 2 mg/kg, or placebo. Across the entire cohort the drug showed only...
Financial Analysis: Galectin Therapeutics (NASDAQ:GALT) & Phio Pharmaceuticals (NASDAQ:PHIO)
Phio Pharmaceuticals (NASDAQ:PHIO) and Galectin Therapeutics (NASDAQ:GALT) are small‑cap biotech stocks compared across nine investment factors. Phio enjoys stronger institutional backing (57% vs 12%) and a higher consensus target price of $14, implying over 1,000% upside, while Galectin’s target is...
HL7 Launches Real‑Time Medical Device Interoperability Accelerator
On March 5, 2026, HL7 International launched the Caliper FHIR Accelerator, an implementation community aimed at real‑time medical device data interoperability. The initiative builds on HL7’s 2025 device‑workgroup and aligns with standards from IEEE, ISO, IEC, and IHE. By extending...
Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
Georgia Tech’s Advanced Technology Development Center announced that two of its HealthTech portfolio companies, Nephrodite and OrthoPreserve, have each received the FDA’s Breakthrough Device designation. The program promises accelerated regulatory interaction, more frequent agency meetings, and priority review. Nephrodite’s solution...
This Dangerous Combo in Your Body Could Raise Death Risk by 83%
Researchers from Brazil’s Federal University of São Carlos and University College London examined 12 years of data from 5,440 adults aged 50 and older and discovered that the coexistence of abdominal obesity and low muscle mass—known as sarcopenic obesity—raises mortality...
Top HHS Official Makes Impassioned Pitch to Take on China Biotech
Senior HHS official and Medicare administrator Chris Klomp warned that competition with China’s rapidly advancing biotech sector is “a war,” signaling heightened urgency in U.S. policy circles. He highlighted gaps in domestic research funding, manufacturing capacity, and talent pipelines that...
Leaders in Lab Automation: Diagnostic Companies Setting the Standard for Efficiency
Laboratory automation is becoming essential as testing volumes surge and workflows grow more complex. Leading diagnostic vendors—Danaher, Siemens Healthineers, and Abbott—offer end‑to‑end platforms that integrate pre‑analytic sorting, AI‑driven error detection, and post‑analytic data management. Danaher’s DxA 5000 claims up to an...
Fidelity Select Health Care Portfolio Q4 2025 Commentary
Health‑care stocks surged 11.47% in Q4 2025, the strongest sector gain in the S&P 500, while the Fidelity Select Health Care Portfolio (FSPHX) posted an 11.10% return, slightly trailing the MSCI health‑care index. The fund’s underperformance stemmed from an underweight position...
‘No Silver Bullet’: The Iterative Staffing Strategies Home-Based Care Providers Need
Home‑based care providers are confronting a rapidly changing caregiver workforce, prompting them to adopt a series of experimental staffing tactics rather than relying on a single solution. Companies such as Caretech and By the Bay Health are building high‑school pipelines,...
Chris Hipkins Says Advice About Covid Vaccine Risk for Teens Arrived Too Late
Former New Zealand Covid Response Minister Chris Hipkins acknowledged that advice warning of increased myocarditis risk from two Pfizer doses in 12‑17‑year‑olds arrived in November 2021, but was not presented to ministers until a March 2022 cabinet briefing when pandemic...
Anti‑Kickback Statute Implications of Physician Estate Planning: OIG Approves Retirement Plan Involving ASC Ownership Transfers
The U.S. Health and Human Services Office of Inspector General issued a favorable advisory opinion on a retiring physician’s three‑phase plan to transfer ownership of a Medicare‑certified ambulatory surgical center. The OIG concluded the plan does not violate the Anti‑Kickback...
Home Testing Kits Could Bridge the Cervical Screening Gap for Disabled Women, New Study Finds
A new study published in the Journal of Medical Screening finds that more than half of physically disabled women in the UK would choose at‑home HPV self‑sampling kits over traditional clinic‑based cervical smears. The research, which surveyed 1,493 women with...
Study Finds Ultra‑Processed Foods Cut Women’s Fertility Odds by 60%
Researchers at McMaster University reported that women who obtain roughly 31% of their calories from ultra‑processed foods face about 60% lower odds of conceiving. The finding, based on data from more than 2,500 women in the NHANES survey, arrives as...
Medical Tourism Is Becoming A Multi-Billion Dollar Business
Medical tourism is evolving into a multi‑billion‑dollar sector, projected to reach roughly $140 billion by 2032 with a 15.12% annual growth rate. Cost‑driven patients are flocking to hubs such as Turkey, where hair‑transplant procedures cost $2,000‑$4,000—about 80% less than U.S. prices—and...
Vytrus Biotech SA Posts 183% Profit Jump as Revenue Climbs 66% to €8.37M
Vytrus Biotech SA announced full‑year earnings of €2.89 million, up 183% from the prior year, while revenue surged 66% to €8.37 million. The results highlight robust market demand for its pipeline and signal momentum for European biotech firms.
Americans Are Now Providing More than $1 Trillion in Unpaid Family Caregiving a Year
AARP reports that 59 million Americans are caring for adult relatives, delivering 49.5 billion hours of unpaid assistance in 2024. Valued at $20.41 per hour, that labor equals roughly $1.01 trillion— a 67 % jump since 2021 and now higher than the nation’s $932 billion...
STAT+: FDA Approves Rocket Gene Therapy for Rare Immune Disorder
The FDA has granted approval to Rocket Pharma's gene therapy Kresladi for severe leukocyte adhesion deficiency type 1 (LAD‑1), an ultra‑rare immune disorder. The therapy was previously rejected in 2024 due to manufacturing concerns, but the agency cleared it after the...
ACLCM Launches Lifestyle Medicine Whole Person Health Index to Embed Holistic Care in EHRs
The American College of Lifestyle Medicine (ACLM) introduced the Lifestyle Medicine Whole Person Health Index (LMWPHI), a point‑of‑care assessment embedded in Epic and slated for eClinicalWorks integration. The tool captures lifestyle data across six pillars, aiming to make whole‑person care...
Neurologists and Patient Call for Routine Spiritual Care in Clinics
A coalition of neurologists from UCLA, Colorado, Harvard and Brown, together with Parkinson’s patient Kirk Hall, published a paper in Neurology Clinical Practice demanding that spiritual care become a standard part of neurological treatment. The authors cite a survey showing...
Ireland Launches Parent‑child Psychological Support Pilot in Wicklow, 90 Families Enrolled
The Department of Children, Disability and Equality inaugurated the Parent–Child Psychological Support (PCPS) pilot at Bray Primary Care Centre, enrolling more than 90 families since its September start. The programme delivers seven structured sessions over the first 18 months of...
GARM Adds Anti‑Aging Klotho to Gene‑Therapy Suite in Honduras
GARM, operating as Longevity Advanced, announced the addition of the anti‑aging protein Klotho to its gene‑therapy portfolio at its Roatán clinic. The move broadens a suite that already includes Follistatin and VEGF, positioning the center as a hub for high‑end...
AI Automates Radiology Tasks, but Radiologists Still Thrive
On Lex Fridman's podcast this week, Jensen Huang brought up radiology and AI, highlighting radiology as an important data point for how we can expect AI to influence jobs. He talked about how nearly a decade ago, AI researchers predicted...
Alpha‑Lipoic Acid Shows Promise for Ischemic Heart Failure
Efficacy of Alpha-Lipoic Acid in Patients With Ischemic Heart Failure: A Double-Blind, Randomized, Placebo-Controlled Study | @JACCJournals https://t.co/nW9SbwEDfy https://t.co/qsemjmMb9k
Eye Drops Made From Pig Semen Deliver Cancer Treatment to Mice
Scientists at Shenyang Pharmaceutical University have engineered eye drops using exosomes derived from pig semen, loaded with a carbon‑dot nanozyme, to breach the retinal barrier in mice. The formulation halted retinoblastoma tumor growth and preserved normal vision over a 30‑day...
GLP‑1 Therapies Show Promising Cardiovascular Benefits
GLP-1 and the cardiovascular system "This Review summarizes the effects of GLP-1 and GLP-1RAs in the CV system..." https://t.co/Sy7Jjb96WD https://t.co/v3T01fIcOs
Questioning Anti‑Tiering Clauses: Policy Recommendations Still Relevant
is there any rationale for allowing anti-tiering, anti steering, and "all or nothing" clauses in hospital contracts with insurers? Barring these was one of the centerpieces of our healthcare competition policy recommendations almost a decade ago https://t.co/8PPf8H5iMw
‘This Is Crazy’: Health Experts Call for Changes to the No Surprises Act
The No Surprises Act, enacted in 2020 to shield patients from unexpected medical bills, relies on an Independent Dispute Resolution (IDR) process when insurers and providers cannot agree on payment. Health‑care leaders now warn that the IDR system is being...
A Fresh Path for Young Physicians and Med Students
Sound and thoughtful advice from @DGlaucomflecken in my recent article on @BakerInstitute website (our policy think thank @RiceUniversity) I’ve proposed an alternative or parallel for young physicians and med students, it’s a bit out there and still half-baked https://t.co/0NN1omZTWk
Billionaires Fund Headless Human Clones for Organ Farms
Billionaire-backed scientists aim to grow 'headless humans' to farm their organs... and help biohackers live for longer https://t.co/uQOzEtBapf https://t.co/HYZCMCOPy3
Health System CIOs Say EHR Downtime Resilience Requires Organization-Wide Ownership, Rehearsed Plans, and Structured Documentation
The panel explored how health systems can achieve operational resilience during EHR downtime, emphasizing that resilience is an organization‑wide capability rather than just an IT issue. CIOs Chris Akeroy (Lee Health) and Stuart James (Christus Health) highlighted the need for...
Uric Acid Predicts Sex‑Specific Cognitive Decline in Seniors
Serum uric acid levels and longitudinal change in cognitive function in older adults: a sex-stratified population-based study https://t.co/vl5LLY6mBc
Public Health Needs Standardized Peptide Nomenclature Committee
Public health discourse needs a nomenclature committee before this “peptides” thing gets out of hand. So many types, so much variation in evidence, so much at stake. Common language would really help everyone: pro and against.
Navigating Myeloma MRD: When to Stop Treatment
MT @hhashmi87 #IMS25 Great Meet The Expert talk by @bdermanmd on MRD in Myeloma Risk vs benefit Who can stop treatment Active surveillance post discontinuation #mmMRD #mmsm https://t.co/Y1ti72KB2p
Lancet Calls for Wider Access to GLP‑1 Drugs
This week's @TheLancet cover and editorial about getting GLP-1 drugs available for the people who need them the most https://t.co/BU9NZdmdGo https://t.co/TWOIKvfuth
MRD‑Negative Patients Can Stop Myeloma Maintenance Therapy
Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP) - @bdermanmd et al. @ajjakubowiak #ASCO24 Abstract 106 https://t.co/FBTY7SnCxK #NCT04108624 #mmsm #mmMRD
ODAC Backs MRD Testing as Early Myeloma Trial Endpoint
A Historic Turning Point: ODAC Unanimously Votes [4/12/24] in Favor of MRD Testing as an Early Endpoint in Myeloma Clinical Trials to Support Accelerated Approvals of New Treatments [Apr 18, 2024] @IMFmyeloma https://t.co/eDOgIrpVeR #mmMRD #mmsm #ctsm @FDAOncology https://t.co/ejA8KSoxOL
Clinicians Show Mixed Adoption of Myeloma MRD Testing
Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] @bdermanmd @jagoda_jasielec @ajjakubowiak Brit J Haematol https://t.co/8zhxYfYwZQ #mmsm #mmMRD https://t.co/lbZ4AFZ1YM